Pathogenesis of Bronchiectasis

Clinics in Chest Medicine

Volumn 28, Issue 2, 2007, Pages 289-296

  Morrissey, Brian M ^a  

^a University of Illinois School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHIECTASIS; CLINICAL FEATURE; CYSTIC FIBROSIS; FORCED EXPIRATORY FLOW; FOREIGN BODY; HUMAN; HYGIENE; INFLAMMATION; INNATE IMMUNITY; LUNG CLEARANCE; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW;

BRONCHIECTASIS; CYSTIC FIBROSIS; HUMANS; INFLAMMATION; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 34247478107     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2007.02.014     Document Type: Review

References (68)

1. Scala R., Aronne D., Palumbo U., et al. Prevalence, age distribution and aetiology of bronchiectasis: a retrospective study on 144 symptomatic patients. Monaldi Arch Chest Dis 55 2 (2000) 101-105
2. Tsao P.C., and Lin C.Y. Clinical spectrum of bronchiectasis in children. Acta Paediatr Taiwan 43 5 (2002) 271-275
3. Barker A.F. Bronchiectasis. N Engl J Med 346 18 (2002) 1383-1393
4. Morrissey B.M., and Harper R.W. Bronchiectasis: sex and gender considerations. Clin Chest Med 25 2 (2004) 361-372
5. Saynajakangas O., Keistinen T., Tuuponen T., et al. Bronchiectasis in Finland: trends in hospital treatment. Respir Med 91 7 (1997) 395-398
6. Saynajakangas O., Keistinen T., Tuuponen T., et al. Evaluation of the incidence and age distribution of bronchiectasis from the Finnish Hospital Discharge Register. Cent Eur J Public Health 6 3 (1998) 235-237
7. Nikolaizik W.H., and Warner J.O. Aetiology of chronic suppurative lung disease. Arch Dis Child 70 2 (1994) 141-142
8. Tiddens H.A. Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 7 3 (2006) 202-208
9. Burgel P.R., Montani D., Danel C., et al. A morphometric study of mucins and small airway plugging in cystic fibrosis. Thorax 62 2 (2007) 153-161
10. Bedrossian C.W., Greenberg S.D., Singer D.B., et al. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol 7 2 (1976) 195-204
11. Cole P.J. Inflammation: a two-edged sword-the model of bronchiectasis. Eur J Respir Dis Suppl 147 (1986) 6-15
12. Ionescu A.A., Nixon L.S., Luzio S., et al. Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis. Am J Respir Crit Care Med 165 4 (2002) 495-500
13. Angrill J., Agusti C., De Celis R., et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 164 9 (2001) 1628-1632
14. Woodring J.H., Howard II R.S., and Rehm S.R. Congenital tracheobronchomegaly (Mounier-Kuhn syndrome): a report of 10 cases and review of the literature. J Thorac Imaging 6 2 (1991) 1-10
15. Dawson M., Wirtz D., and Hanes J. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J Biol Chem 278 50 (2003) 50393-50401
16. Bush A., Payne D., Pike S., et al. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest 129 1 (2006) 118-123
17. Lethem M.I., James S.L., and Marriott C. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum. Am Rev Respir Dis 142 5 (1990) 1053-1058
18. Widdicombe J.H., and Wine J.J. The basic defect in cystic fibrosis. Trends Biochem Sci 16 12 (1991) 474-477
19. Houtmeyers E., Gosselink R., Gayan-Ramirez G., et al. Regulation of mucociliary clearance in health and disease. Eur Respir J 13 5 (1999) 1177-1188
20. Carlen B., and Stenram U. Primary ciliary dyskinesia: a review. Ultrastruct Pathol 29 3-4 (2005) 217-220
21. Cornillie F.J., Lauweryns J.M., and Corbeel L. Atypical bronchial cilia in children with recurrent respiratory tract infections. A comparative ultrastructural study. Pathol Res Pract 178 6 (1984) 595-604
22. Bertrand B., Collet S., Eloy P., et al. Secondary ciliary dyskinesia in upper respiratory tract. Acta Otorhinolaryngol Belg 54 3 (2000) 309-316
23. Widdicombe J.H. Regulation of the depth and composition of airway surface liquid. J Anat 201 4 (2002) 313-318
24. Doring G. Mechanisms of airway inflammation in cystic fibrosis. Pediatr Allergy Immunol 7 9 Suppl (1996) 63-66
25. Finkbeiner W.E. Physiology and pathology of tracheobronchial glands. Respir Physiol 118 2-3 (1999) 77-83
26. Lamblin G., Degroote S., Perini J.M., et al. Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis. Glycoconj J 18 9 (2001) 661-684
27. Schulz B.L., Sloane A.J., Robinson L.J., et al. Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions. Biochem J 387 Pt 3 (2005) 911-919
28. Jayaraman S., Joo N.S., Reitz B., et al. Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity. Proc Natl Acad Sci U S A 98 14 (2001) 8119-8123
29. Machen T.E. Innate immune response in CF airway epithelia: hyperinflammatory?. Am J Physiol Cell Physiol 291 2 (2006) C218-C230
30. Zar H., Saiman L., Quittell L., et al. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J Pediatr 126 2 (1995) 230-233
31. Kubo K., Yamazaki Y., Hachiya T., et al. Mycobacterium avium-intracellulare pulmonary infection in patients without known predisposing lung disease. Lung 176 6 (1998) 381-391
32. Noone P.G., and Knowles M.R. 'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2 6 (2001) 328-332
33. Ip M., Shum D., Lauder I., et al. Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis. Respir Med 87 6 (1993) 449-454
34. Osika E., Cavaillon J.M., Chadelat K., et al. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J 14 2 (1999) 339-346
35. Dakin C.J., Numa A.H., Wang H., et al. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 165 7 (2002) 904-910
36. Khan T.Z., Wagener J.S., Bost T., et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151 4 (1995) 1075-1082
37. Armstrong D.S., Hook S.M., Jamsen K.M., et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 40 6 (2005) 500-510
38. Chmiel J.F., and Davis P.B. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?. Respir Res 4 (2003) 8
39. Heeckeren A., Walenga R., Konstan M.W., et al. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100 11 (1997) 2810-2815
40. Barton A.D., Ryder K., Lourenco R.V., et al. Inflammatory reaction and airway damage in cystic fibrosis. J Lab Clin Med 88 3 (1976) 423-426
41. Mendis A.H., Venaille T.J., and Robinson B.W. Study of human epithelial cell detachment and damage: effects of proteases and oxidants. Immunol Cell Biol 68 Pt 2 (1990) 95-105
42. Amitani R., Wilson R., Rutman A., et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol 4 1 (1991) 26-32
43. Sirmali M., Turut H., Kisacik E., et al. The relationship between time of admittance and complications in paediatric tracheobronchial foreign body aspiration. Acta Chir Belg 105 6 (2005) 631-634
44. Morrissey B.M., and Evans S.J. Severe bronchiectasis. Clin Rev Allergy Immunol 25 3 (2003) 233-247
45. Vandivier R.W., Henson P.M., and Douglas I.S. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129 6 (2006) 1673-1682
46. Halliwell B., and Cross C.E. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 102 Suppl 10 (1994) 5-12
47. Berger M., Sorensen R.U., Tosi M.F., et al. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest 84 4 (1989) 1302-1313
48. Wilson R., Dowling R.B., and Jackson A.D. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Respir J 9 7 (1996) 1523-1530
49. Prince A.S. Biofilms, antimicrobial resistance, and airway infection. N Engl J Med 347 14 (2002) 1110-1111
50. Li Z., Kosorok M.R., Farrell P.M., et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293 5 (2005) 581-588
51. de Bentzmann S., Roger P., and Puchelle E. Pseudomonas aeruginosa adherence to remodelling respiratory epithelium. Eur Respir J 9 10 (1996) 2145-2150
52. Denning G.M., Railsback M.A., Rasmussen G.T., et al. Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. Am J Physiol 274 6 Pt 1 (1998) L893-L900
53. Hingley S.T., Hastie A.T., Kueppers F., et al. Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia. Infect Immun 51 1 (1986) 254-262
54. Morrissey B.M., and Louie S. Allergic bronchopulmonary aspergillosis: an evolving challenge in asthma. In: Gershwin M.E., and Albertson T.E. (Eds). Bronchial asthma, a guide for practical understanding and treatment. 5th edition (2006), Humana Press, Totowa (NJ) 279-309
55. Knutsen A.P., Bellone C., and Kauffman H. Immunopathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis. J Cyst Fibros 1 2 (2002) 76-89
56. Amitani R., Murayama T., Nawada R., et al. Aspergillus culture filtrates and sputum sols from patients with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium in vitro. Eur Respir J 8 10 (1995) 1681-1687
57. Robinson B.W., Venaille T.J., Mendis A.H., et al. Allergens as proteases: an Aspergillus fumigatus proteinase directly induces human epithelial cell detachment. J Allergy Clin Immunol 86 5 (1990) 726-731
58. Goldman M.J., Anderson G.M., Stolzenberg E.D., et al. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88 4 (1997) 553-560
59. Chilvers M.A., and O'Callaghan C. Local mucociliary defence mechanisms. Paediatr Respir Rev 1 1 (2000) 27-34
60. Bals R., Wang X., Wu Z., et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102 5 (1998) 874-880
61. Drumm M.L., Konstan M.W., Schluchter M.D., et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353 14 (2005) 1443-1453
62. Kelly F.J. Vitamins and respiratory disease: antioxidant micronutrients in pulmonary health and disease. Proc Nutr Soc 64 4 (2005) 510-526
63. Friedman K.J., and Silverman L.M. Cystic fibrosis syndrome: a new paradigm for inherited disorders and implications for molecular diagnostics. Clin Chem 45 7 (1999) 929-931
64. Huber A.R., and Weiss S.J. Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J Clin Invest 83 4 (1989) 1122-1136
65. Delclaux C., Delacourt C., D'Ortho M.P., et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 14 3 (1996) 288-295
66. Sepper R., Konttinen Y.T., Sorsa T., et al. Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Chest 106 4 (1994) 1129-1133
67. Reijerkerk A., Kooij G., van der Pol S.M., et al. Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. Faseb J 20 14 (2006) 2550-2552
68. Zheng L., Lam W.K., Tipoe G.L., et al. Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo. Eur Respir J 20 1 (2002) 170-176